A Smart + Strong Site
Subscribe to:
Newsletters
POZ magazine
JOIN AIDSMEDS YouTube

Back to home » Treatment News » Top Stories

Most Popular Stories
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
FDA Approves New Single-Tablet HIV Regimen, Triumeq
Life Expectancy for Young People With HIV Is Nearly Normal
A 15-Year Jump in Life Expectancy for People With HIV
Scientists Devise Method of Snipping HIV From Immune Cells
Monkey HIV Vaccine Success Opens Door for Human Trials
HIV Combo Pill Less Toxic Thanks to New Form of Tenofovir
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to news@aidsmeds.com.

Click here for more news


emailprint

January 18, 2013

New Look at Failed 2009 Vaccine Study Yields Promising Leads

Further study into the sole HIV vaccine trial to demonstrate moderate effectiveness has yielded new findings that may point to a future vaccine when combined with other recent scientific discoveries, PlusNews.org reports. Publishing their paper in the journal Immunity, researchers from Duke University, the Thailand Ministry of Public Health and the U.S. Military HIV Research Program studied data from the six-year vaccine trial in Thailand called RV144. This study of 16,000 HIV-negative adults, whose results were released in 2009, showed that the investigatory vaccine reduced infection rates by 31 percent, which was short of the minimum 50 percent effectiveness epidemiologists say is needed to turn the tide of the epidemic.

According to the new study, the vaccine prompted four separate antibodies to mark the virus on a key site on the surface of HIV-infected cells. These indications alerted the so-called “killer T-cells” to attack and kill the infected cells. However, the researchers have stated that they cannot be sure this reaction was the cause of what protection the vaccine did provide against infection. Still, when added to the recent discovery that the immune system’s “broadly neutralizing antibodies” can effectively target the virus, this new understanding of the body’s natural defense mechanisms may one day contribute to the development of a more comprehensive, complex and ultimately effective vaccine.

To read the PlusNews.org story, click here.

To read the study abstract, click here.

Search: HIV, vaccine, PlusNews.org, Duke University, Thailand Ministry of Public Health, U.S. Military HIV Research Program, RV144, killer T-cells, broadly neutralizing antibodies.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team reviews all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (1 total)


[Go to top]

Quick Links
About HIV and AIDS
The Cure
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    fokisi
    Long Beach
    California


    koffeeboss
    Tucson
    Arizona


    Deelight4u
    BROOKLYN
    New York


    albsur7436
    San Francisco
    California
Click here to join POZ Personals!
Conference Coverage

XX International AIDS Conference
(AIDS 2014)
Melbourne, Australia
July 20 - 25, 2014


21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014


7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.